EUR 53.4
(2.5%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 4.76 EUR | 81.68% |
2022 | 2.62 EUR | 318.33% |
2021 | -1.20 EUR | -122.22% |
2020 | -0.54 EUR | -134.78% |
2019 | -0.23 EUR | -130.67% |
2018 | 0.75 EUR | 541.18% |
2017 | -0.17 EUR | 62.22% |
2016 | -0.45 EUR | -807.55% |
2015 | 0.06 EUR | -36.21% |
2014 | 0.10 EUR | 112.95% |
2013 | -0.77 EUR | -48.08% |
2012 | -0.52 EUR | -85.71% |
2011 | -0.28 EUR | -180.0% |
2010 | -0.10 EUR | -141.55% |
2009 | -0.04 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.58 EUR | 0.0% |
2023 Q2 | 0.11 EUR | 0.0% |
2023 Q4 | 4.61 EUR | 0.0% |
2023 FY | - EUR | 81.68% |
2022 FY | - EUR | 318.33% |
2022 Q2 | 6.51 EUR | 0.0% |
2022 Q4 | -2.91 EUR | 0.0% |
2021 Q2 | -0.92 EUR | 0.0% |
2021 Q4 | -0.30 EUR | 0.0% |
2021 FY | - EUR | -122.22% |
2020 Q4 | -0.41 EUR | 0.0% |
2020 FY | - EUR | -134.78% |
2020 Q2 | -0.14 EUR | 0.0% |
2019 Q2 | -0.07 EUR | 0.0% |
2019 FY | - EUR | -130.67% |
2019 Q4 | -0.16 EUR | 0.0% |
2018 Q4 | -0.05 EUR | 0.0% |
2018 Q2 | 0.81 EUR | 0.0% |
2018 FY | - EUR | 541.18% |
2017 Q4 | 0.14 EUR | 0.0% |
2017 FY | - EUR | 62.22% |
2017 Q2 | -0.32 EUR | 0.0% |
2016 FY | - EUR | -807.55% |
2016 Q2 | -0.13 EUR | 0.0% |
2016 Q4 | -0.32 EUR | 0.0% |
2015 Q4 | - EUR | 0.0% |
2015 Q2 | - EUR | 0.0% |
2015 FY | - EUR | -36.21% |
2014 FY | - EUR | 112.95% |
2014 Q4 | - EUR | 0.0% |
2014 Q2 | - EUR | 0.0% |
2013 Q3 | -0.19 EUR | 0.0% |
2013 FY | - EUR | -48.08% |
2013 Q4 | 0.02 EUR | 113.11% |
2013 Q2 | -0.19 EUR | 0.0% |
2013 Q1 | -0.19 EUR | 0.0% |
2012 Q3 | -0.06 EUR | 0.0% |
2012 Q1 | -0.06 EUR | 0.0% |
2012 Q4 | -0.19 EUR | -217.2% |
2012 Q2 | -0.06 EUR | 0.0% |
2012 FY | - EUR | -85.71% |
2011 Q2 | -0.07 EUR | 0.0% |
2011 Q1 | -0.07 EUR | 0.0% |
2011 FY | - EUR | -180.0% |
2011 Q3 | -0.07 EUR | 0.0% |
2011 Q4 | -0.06 EUR | 14.67% |
2010 Q1 | -0.03 EUR | 0.0% |
2010 FY | - EUR | -141.55% |
2010 Q4 | -0.07 EUR | -178.57% |
2010 Q3 | -0.03 EUR | 0.0% |
2010 Q2 | -0.03 EUR | 0.0% |
2009 Q4 | -0.03 EUR | -144.66% |
2009 Q2 | -0.01 EUR | 0.0% |
2009 Q1 | -0.01 EUR | 0.0% |
2009 Q3 | -0.01 EUR | 0.0% |
2009 FY | - EUR | 0.0% |
2008 Q4 | -0.01 EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
BioNTech SE | 3.87 EUR | -22.997% |
CureVac N.V. | -1.18 EUR | 503.39% |
Biotest Aktiengesellschaft | 3.21 EUR | -48.287% |
Biotest Aktiengesellschaft | 3.21 EUR | -48.287% |
BRAIN Biotech AG | -0.38 EUR | 1352.632% |
Heidelberg Pharma AG | -0.44 EUR | 1181.818% |
Medigene AG | -0.66 EUR | 821.212% |